No cognitive effects seen after years of very low LDL cholesterol
Having an extremely low LDL level from aggressive cholesterol-lowering therapy was not associated with cognitive impairment, according to a new study. The study was an extension of an earlier investigation of people with heart disease that compared the cognitive effects of taking the cholesterol-lowering drug evolocumab (Repatha) plus a statin to taking a statin only. … Read more